Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Initiation of allergic responses in lung
EF 2013-14
Résumé
Naïve CD4+ T cells are capable of differentiating into a diverse range of subsets including T helper 1 (TH1), and T helper 2 (TH1) cells, pivotal mediators of the adaptive immune response. TH1 cells respond to intracellular pathogen invasion by secreting IFN-?, IL-2 and TNF-í and activating macrophages and cytotoxic T cells (type 1 immunity). TH2 cells respond to extracellular parasites and allergens, by secreting interleukin 4 (IL-4), IL-5 and IL-13 which activate B cells, enhances mucus production, and recruits eosinophils and mast cells (type 2 immunity).
The drivers for type 1 immunity have been studied extensively. TH2 cell differentiation is thought to be initiated by IL-4 binding to its receptor, which induces GATA-3, the master regulator of TH2 cell cytokine genes. However, IL-4 and IL-4 receptor knockout mice can still induce a robust in vivo TH2 response. Currently, this IL-4-independent pathway is not well understood.
Previous studies in our laboratory have found a unique population of innate lymphoid cells, termed ILC2, that produce type 2 cytokines (ILC2s) in mouse lungs. Interestingly, TH2 cell response is attenuated in ILC2-deficient mice, demonstrating that ILC2s have a critical role in TH2 cell differentiation. Our studies have shown that ILC2-derived IL-13, but not IL-4, is required for TH2 cell differentiation. IL-13 does not act on TH cells but rather it stimulates dendritic cells (DCs), the key antigen presenting cells, and induces migration of DCs from the lung to the draining lymph node where naïve CD4 T cells are stimulated and differentiate into TH2 cells.
The goal for this project is to elucidate the mechanisms by which ILC2-derived IL-13 induces TH2 polarization. My hypothesis is that ILC2-derived IL-13 induces unique co-stimulatory molecule(s) on dendritic cells (DCs) that binds to co-receptor(s) on naïve CD4+ T cells and induces TH2 polarization. Non-beneficial responses to environmental stimuli at mucosal surfaces predominately results in type 2 immunity and can result in fibrotic or allergic disease. Understanding how type 2 immunity is initiated in the lung will have important implications towards allergic diseases as well as immunotherapies in general.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
312020
Name
Steer Catherine
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Initiation of allergic responses in lung
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Allergy; Dendritic Cells; Innate Lymphoid Cells; Interleukin-13; Th2 Differentiation; Type 2 Inflammation
Abstract
Naïve CD4+ T cells are capable of differentiating into a diverse range of subsets including T helper 1 (TH1), and T helper 2 (TH1) cells, pivotal mediators of the adaptive immune response. TH1 cells respond to intracellular pathogen invasion by secreting IFN-?, IL-2 and TNF-í and activating macrophages and cytotoxic T cells (type 1 immunity). TH2 cells respond to extracellular parasites and allergens, by secreting interleukin 4 (IL-4), IL-5 and IL-13 which activate B cells, enhances mucus production, and recruits eosinophils and mast cells (type 2 immunity).
The drivers for type 1 immunity have been studied extensively. TH2 cell differentiation is thought to be initiated by IL-4 binding to its receptor, which induces GATA-3, the master regulator of TH2 cell cytokine genes. However, IL-4 and IL-4 receptor knockout mice can still induce a robust in vivo TH2 response. Currently, this IL-4-independent pathway is not well understood.
Previous studies in our laboratory have found a unique population of innate lymphoid cells, termed ILC2, that produce type 2 cytokines (ILC2s) in mouse lungs. Interestingly, TH2 cell response is attenuated in ILC2-deficient mice, demonstrating that ILC2s have a critical role in TH2 cell differentiation. Our studies have shown that ILC2-derived IL-13, but not IL-4, is required for TH2 cell differentiation. IL-13 does not act on TH cells but rather it stimulates dendritic cells (DCs), the key antigen presenting cells, and induces migration of DCs from the lung to the draining lymph node where naïve CD4 T cells are stimulated and differentiate into TH2 cells.
The goal for this project is to elucidate the mechanisms by which ILC2-derived IL-13 induces TH2 polarization. My hypothesis is that ILC2-derived IL-13 induces unique co-stimulatory molecule(s) on dendritic cells (DCs) that binds to co-receptor(s) on naïve CD4+ T cells and induces TH2 polarization. Non-beneficial responses to environmental stimuli at mucosal surfaces predominately results in type 2 immunity and can result in fibrotic or allergic disease. Understanding how type 2 immunity is initiated in the lung will have important implications towards allergic diseases as well as immunotherapies in general.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Steer, Catherine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~